EPAM Systems EPAM Climbs 798 Resistance at 10546 in Focus 20260518 What Comfort FIXs 293 Decline Means for Investors 20260515 West WFG Rallies 062 as Bulls Target 6257 20260518 TrumpXi Summit in Beijing Five Key Factors for Asia Markets This Week India No Longer Optional for Global Investors Say DWS and Nippon Life AMC Amid FII Outflows BEKE Q4 2025 Earnings EPS Misses Estimates Amid Market Headwinds Nvidia Revenue Surges Past Expectations as AI Infrastructure Expansion Accelerates Stephen Miran Exits the Federal Reserve Policy Foundations for Kevin Warshs Incoming Tenure Qualcomm Stock Surge Highlights Investor Confidence in AI Device Boom Sindhu Trade Links Shares Surge After Approving Acquisitions and Capital Hike Consumer Credit Growth Accelerates in December Signaling Resilient Spending Memory Chip Crunch Poses New Challenges for Chinese Automakers From BYD to Xpeng Surging Gas Prices Hit LowerIncome Households Harder New York Fed Study Shows Dow Jones Futures Eye Iran Deal Progress Tesla and AI Stocks at Potential Buy Points Annovis Bio ANVS Q1 2026 Earnings EPS Miss Widens as Pipeline Costs Mount Stock Declines FNV Q1 2026 Earnings Strong EPS Beat Signals Resilient Royalty Portfolio Xcel Energy XEL Q1 2026 Earnings Slump EPS Falls Short of 091 Target PLMR Q1 2026 Earnings Earnings Beat Driven by Underwriting Strength DUK Q1 2026 Earnings EPS Surpasses Estimates as Duke Energy Delivers Steady Operations Citi Raises Price Target on Frontier Group Holdings After Record Q1 Revenue IBEX Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher AutoZone Q1 2026 Earnings EPS Surpasses Estimates by 084 Stock Edges Lower Katapult Holdings Q1 2026 Earnings Massive EPS Surprise on Minimal Expectations Dine Brands Q1 2026 Earnings EPS Beats Estimates by 53 Amid Operational Discipline EVGO Q1 2026 Earnings NarrowerThanExpected Loss Highlights Operational Discipline SLG Q1 2026 Earnings EPS Misses Amid Market Volatility Stock Rises on Operational Resilience CNP Q1 2026 Earnings Slight EPS Miss Amidst Operational Progress PRLD Q1 2026 Earnings Narrower Loss Than Anticipated as Clinical Pipeline Advances